1 / 8

Dr Agarwals Healthcare IPO: GMP, Price, Date & Full Details

Explore Dr Agarwals Healthcare IPO details, including gmp, price range (Rs.382-Rs.402), issue date (29-31 Jan 2025), and expected listing on 5 Feb 2025.

sonu69
Télécharger la présentation

Dr Agarwals Healthcare IPO: GMP, Price, Date & Full Details

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dr Agarwals Healthcare IPO Overview A Comprehensive Analysis of Dr Agarwals Healthcare IPO

  2. Introduction to Dr Agarwals Healthcare IPO • • Dr Agarwals Healthcare Limited, established in 2010, is a leading provider of eye care services in India. • • IPO size: Rs. 3,027.26 Cr with a price band of Rs. 382 - Rs. 402 per share. • • IPO dates: 29th Jan 2025 to 31st Jan 2025. • • Listing Date: 5th Feb 2025 on BSE and NSE.

  3. IPO Details • • Total Issue Size: Rs. 3,027.26 Cr (7,53,04,970 Shares). • • Fresh Issue: Rs. 300 Cr (0.75 Cr shares). • • Offer for Sale: Rs. 2,727.26 Cr (6.78 Cr shares). • • Lot Size: 35 shares (Minimum Investment: Rs. 14,070).

  4. Company Financials (in Cr) • • Total Revenue (FY2024): Rs. 837.94. • • PAT (Profit After Tax): Rs. 39.56. • • Total Assets: Rs. 3,393.41. • • Net Worth: Rs. 1,502.67.

  5. Strengths & Weaknesses • Strengths: • • Leading provider of ophthalmic services. • • Scalable asset-light business model. • • Robust clinical practices and innovative technology. • Weaknesses: • • High geographic concentration. • • Regulatory compliance risks. • • High valuation compared to industry peers.

  6. GMP & Evaluation • • GMP (Grey Market Premium): Rs. 60 as of 24th Jan 2025. • • Estimated Listing Price: Rs. 462. • • P/E Ratio: 128.02x (higher than industry average of 82.44x). • • IPO appears aggressively priced for investors.

  7. Key IPO Dates • • IPO Opening Date: 29th January 2025. • • IPO Closing Date: 31st January 2025. • • Allotment Date: 3rd February 2025. • • Refund Initiation: 4th February 2025. • • Listing Date: 5th February 2025.

  8. Conclusion • • Dr Agarwals Healthcare IPO is a promising investment in the healthcare sector. • • Strong growth and market leadership in eye care services. • • However, investors should weigh the high valuation and associated risks before investing.

More Related